Handelsavisen
prelaunch
Companies Healthcare 8247.HK
82
8247.HK HKEX Medical Equipment, Supplies & Distribution

8247.Hk

HK$2,86
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
413,9M HKD
P/E
EV / Rev
Div yield
Op margin
-32,8 %
ROE
-42,5 %
Net margin
-27,8 %
Debt / equity
1,36
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.

Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-42,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 8247.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 8247.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company's capital structure is characterized by a debt-to-equity ratio of 1.36, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 0.82, suggesting that the company's current liabilities exceed its current assets. The company's price-to-book ratio is 3.61, which is relatively high, and its price-to-tangible-book ratio is the same, indicating that the market is valuing the company's intangible assets at a premium. The company's enterprise value to EBITDA ratio is negative at -9.14, reflecting its current unprofitability.

    Profitability metrics show that the company is currently unprofitable, with a net income of -51,142,000 CNY and an operating income of -60,536,000 CNY. The return on equity is -0.4255, and the return on assets is -0.1256, both of which are negative, indicating poor performance relative to its equity and asset base. The gross profit margin is 38.48%, which is a positive sign, but the operating margin is -32.85%, highlighting significant operational inefficiencies.

    The company's revenue is concentrated in a single segment, as no segmental breakdown is provided in the available data. There is no information on geographic exposure, but the company's operations are likely concentrated in its primary market. The lack of diversification in revenue sources could pose a risk to the company's stability.

    The company's growth trajectory is uncertain, as there is no outlook data provided for the current or next fiscal year. The company's operating cash flow is negative at -25,841,000 CNY, and its free cash flow is also negative at -53,931,000 CNY, indicating that the company is not generating sufficient cash to fund its operations or growth initiatives. The capital expenditure of -6,770,000 CNY suggests that the company is investing in its operations, but the negative value indicates a reduction in capital spending.

    The company's risk assessment indicates a medium liquidity risk, with a current ratio of 0.82, and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights the company's liquidity challenges. The company's unprofitability and negative cash flows increase the risk of further financial distress. The dilution potential is low, but the company's financial position may necessitate additional financing, which could lead to dilution in the future.

    There are no recent events or filings provided in the available data to inform the company's current situation. The lack of recent information makes it difficult to assess the company's response to market conditions or strategic initiatives.

    Key takeaways
    • The company is currently unprofitable, with a net income of -51,142,000 CNY and an operating income of -60,536,000 CNY.
    • The company's liquidity position is medium, with a current ratio of 0.82, indicating that current liabilities exceed current assets.
    • The company's debt-to-equity ratio is 1.36, suggesting a moderate reliance on debt financing.
    • The company's return on equity is -0.4255, and the return on assets is -0.1256, both of which are negative, indicating poor performance.
    • The company's operating cash flow is negative at -25,841,000 CNY, and its free cash flow is also negative at -53,931,000 CNY.
    • The company's capital expenditure is -6,770,000 CNY, indicating a reduction in capital spending.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    HK$2,86
    Market cap
    HK$434.1M
    Enterprise value
    HK$553.5M
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    3.6x
    P / Tangible book
    3.6x
    Tangible book
    HK$120.2M
    Net cash
    -HK$119.4M
    Current ratio
    0.8
    Debt / equity
    1.4
    ROA
    -12.6%
    ROE
    -42.5%
    Cash conversion
    51.0%
    CapEx / revenue
    -3.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-32,9 %Bottom quartile
    Net Margin-27,8 %Bottom quartile
    ROE-42,5 %Bottom quartile
    Capex / Rev-3,7 %Above median
    D/E1,36Bottom quartile
    Cash Conv0,51Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    Source documents
    • 8247.HK Market data — financials · 2026-05-27

    Ownership & reference

    Leadership

    • Lebin WuExecutive Chairman of the Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    8247.HKCanonical
    HKEX · HKD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage